BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 32642841)

  • 1. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity.
    Padegimas A; Clasen S; Ky B
    Trends Cardiovasc Med; 2020 Jan; 30(1):22-28. PubMed ID: 30745071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Cardiovascular Toxicities Induced by Cancer Therapies and Promising Biomarkers for Their Prediction: A Scoping Review.
    Yan T; Yu H; Li T; Dong Y
    Heart Lung Circ; 2024 May; 33(5):605-638. PubMed ID: 38242833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-naïve malignancy causes cardiovascular disease: a state-of-the-art cardio-oncology perspective.
    Ogilvie LM; Coyle-Asbil B; Brunt KR; Petrik J; Simpson JA
    Am J Physiol Heart Circ Physiol; 2024 Jun; 326(6):H1515-H1537. PubMed ID: 38639740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
    Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
    Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Italian Society of Pediatric Cardiology (SICP) position paper on the prevention, diagnosis, treatment and follow-up of cardiotoxicity in pediatric patients with cancer].
    Bennati E; Castaldi B; Derchi ME; Spoto S; Chinali M; Bertorello N; Comparato C; Vairo U; Rinelli G; Favilli S
    G Ital Cardiol (Rome); 2024 Jun; 25(6):453-463. PubMed ID: 38808942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients.
    Schiffer W; Pedersen LN; Lui M; Bergom C; Mitchell JD
    Curr Cardiol Rep; 2023 Nov; 25(11):1589-1600. PubMed ID: 37796395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future Directions in Cardio-Oncology.
    Trachtenberg BH
    Methodist Debakey Cardiovasc J; 2019; 15(4):300-302. PubMed ID: 31988691
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs.
    Molinaro M; Ameri P; Marone G; Petretta M; Abete P; Di Lisa F; De Placido S; Bonaduce D; Tocchetti CG
    Biomed Res Int; 2015; 2015():138148. PubMed ID: 26583088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic drugs inducing cardiac and vascular toxicity - An update.
    Barachini S; Ghelardoni S; Varga ZV; Mehanna RA; Montt-Guevara MM; Ferdinandy P; Madonna R
    Vascul Pharmacol; 2023 Dec; 153():107223. PubMed ID: 37678516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
    Plana JC; Galderisi M; Barac A; Ewer MS; Ky B; Scherrer-Crosbie M; Ganame J; Sebag IA; Agler DA; Badano LP; Banchs J; Cardinale D; Carver J; Cerqueira M; DeCara JM; Edvardsen T; Flamm SD; Force T; Griffin BP; Jerusalem G; Liu JE; Magalhães A; Marwick T; Sanchez LY; Sicari R; Villarraga HR; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1063-93. PubMed ID: 25239940
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular Magnetic Resonance in the Oncology Patient.
    Jordan JH; Todd RM; Vasu S; Hundley WG
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1150-1172. PubMed ID: 30092971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.
    Hahn VS; Lenihan DJ; Ky B
    J Am Heart Assoc; 2014 Apr; 3(2):e000665. PubMed ID: 24755151
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship.
    de Wall C; Bauersachs J; Berliner D
    Clin Exp Metastasis; 2021 Aug; 38(4):361-371. PubMed ID: 34117981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and management of patients with heart disease and cancer: cardio-oncology.
    Herrmann J; Lerman A; Sandhu NP; Villarraga HR; Mulvagh SL; Kohli M
    Mayo Clin Proc; 2014 Sep; 89(9):1287-306. PubMed ID: 25192616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-oncology in the older adult.
    Reddy P; Shenoy C; Blaes AH
    J Geriatr Oncol; 2017 Jul; 8(4):308-314. PubMed ID: 28499724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cancer patient and cardiology.
    Zamorano JL; Gottfridsson C; Asteggiano R; Atar D; Badimon L; Bax JJ; Cardinale D; Cardone A; Feijen EAM; Ferdinandy P; López-Fernández T; Gale CP; Maduro JH; Moslehi J; Omland T; Plana Gomez JC; Scott J; Suter TM; Minotti G
    Eur J Heart Fail; 2020 Dec; 22(12):2290-2309. PubMed ID: 32809231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity and oncological treatments.
    Schlitt A; Jordan K; Vordermark D; Schwamborn J; Langer T; Thomssen C
    Dtsch Arztebl Int; 2014 Mar; 111(10):161-8. PubMed ID: 24666651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.
    Shelburne N; Adhikari B; Brell J; Davis M; Desvigne-Nickens P; Freedman A; Minasian L; Force T; Remick SC
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25210198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-oncology: what you need to know now for clinical practice and echocardiography.
    Larsen CM; Mulvagh SL
    Echo Res Pract; 2017 Mar; 4(1):R33-R41. PubMed ID: 28254996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.